Event

Nancy Sullivan Speaking at BioPathways + Women In Bio: Funding University Deep Tech

MAY 11, 2021 — 5:00 PM - 6:00 PM

Illinois Ventures CEO and Managing Director Nancy Sullivan will speak at the May SmartHealth Catalyzer BioPathways event focused on funding university technologies.

Nancy has first-hand experience in life science startups. Prior to joining Illinois Ventures, she served as Senior Director of Business Development for an early-stage biotechnology company where she led business development and managed the corporate office operations. She is respected for her skill in identifying, supporting, and growing successful startups and understands how life science innovation and tech investment can deliver returns while lifting economies. Nancy spent her early career in startup formation and technology commercialization with a focus on business development and deal generation. A Chicago native, Nancy is deeply invested in the local and state-wide life science and startup ecosystem. 

She led investments in life science companies including Revolution Medicines (RVMD), which entered the public market in 2020. Nancy led the team’s investments in early-stage healthcare companies including Sfunga Therapeutics, Cystetic medicines, Apervita, Actuate, Photonicare, Keywise AI, and Psyonic.

BioPathways is a monthly SmartHealth Catalyzer event series, featuring prominent bioentrepreneurs, biotech executives, and biotech investors in a fireside chat. In partnership with Women in Bio, BioPathways features prominent female biotech founders, executives, and VCs.

Learn more and register for the BioPathways Women in Bio Funding University Deeptech event here.